Nutriband Inc. Initiates Plans To Offer Topical Lotion Contract Manufacturing Services
Nutriband Inc. Initiates Plans To Offer Topical Lotion Contract Manufacturing Services
Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services, and the manufacture of transdermal products, today announced plans to start offering contract manufacturing services for liquid based topical, transdermal and cosmetic product's. This follows the recent certification as a cGMP facility following a full cGMP audit. The audit was conducted specifically in relation to the certification of Pharmaceutical OTC GMP, 21 CFR Part 211/210.
亞洲網加利福尼亞州聖何塞3月14日電從事醫藥產品開發、合同研究和開發服務以及透皮產品製造的營養帶公司(納斯達克代碼：NTRBW)今天宣佈，計劃開始提供液體外用、透皮和化粧品的合同製造服務。此前，該公司最近在經過全面的cGMP審計後獲得了cGMP設施的認證。該審核是專門針對製藥非處方藥GMP(美國聯邦法規第21編第211/210部分)的認證進行的。
"Our goal is to continue to expand our contract manufacturing capabilities to enhance the Company's revenue opportunities," said Gareth Sheridan, CEO. "Adding liquid based options such as lotions and cosmetics to our contract capabilities is core to this goal and in line with opportunities and relationships we have developed heading into 2022."
首席執行官加雷斯·謝裏丹説：“我們的目標是繼續擴大我們的合同製造能力，以增加公司的收入機會。”在我們的合同能力中增加基於液體的選擇，如乳液和化粧品，是這一目標的核心，符合我們在2022年之前發展起來的機會和關係。“
譯文內容由第三人軟體翻譯。